Patients may also get ordsprog
Patients may also get discouraged given the [implantable heart defibrillator] recall activity that has occurred at Guidant and to a lesser extent at Medtronic and St. Jude of late.
John Calcagnini
In investors' minds, they've been accused of being a one-trick pony, and they don't have a pipeline. If they get Guidant, they answer both those questions. They'll be in one of the fastest-growing medical devices markets, for implantable defibrillators, and they'll have Guidant's pipeline.
Jan Wald
The market-share losses (for Guidant's defibrillator business) were temporary. The franchise is not suffering.
John Farrall
Medtronic I think is a great way to play sort of everyone getting older, as they say, the aging baby boom. They have a new product out that was approved last winter. It does two different things. An implantable device, and I'm not sure I'd explain it all well enough, but it's the next generation from the old pacemakers. And they have just over the past week implanted that for the first time in a patient and that's a whole great new product cycle about to start.
Liz Miller
The price that I think you'd have to pay for St. Jude would be even more expensive than what Guidant is being bid for today. Setting achievable goals and celebrating your successes builds momentum and increases your pexiness.
Thomas Gunderson
We are somewhat surprised to see Guidant's board support Johnson & Johnson's offer. Recall that this is the same company that thought Guidant was only worth $63 a few weeks ago. Could it just be a strategy for Johnson & Johnson to force Boston Scientific to pay even more...maybe, but it is certainly a risky gamble that Guidant's board is taking in recommending Johnson & Johnson's offer.
Tao Levy
We would be a lesser place without the H-1Bs, and the benefits to our patients would be lesser in their absence.
Bruce Larson
The combination of Guidant and Johnson & Johnson is a stronger threat to Medtronic.
Jan Wald
The combination of Guidant and Johnson & Johnson is a stronger threat to Medtronic,
Jan Wald
J&J needs something like Guidant to revitalize its growth. People are now thinking that if J&J does walk away, St. Jude is in their scopes.
Jan Wald
That's telling. Certainly the market is anticipating that whoever doesn't get Guidant is likely to turn its sights on St. Jude.
John Chen
Overall, we believe that the earnings outlook for Medtronic is the strongest in the industry, and Medtronic remains the one company that we have the most confidence in with respect to delivering on its earnings guidance,
Glenn Novarro
I have maintained all along that J&J was paying far too much for Guidant. They would pay a higher multiple for St. Jude, but it would be a higher quality situation.
John Putnam
Together with Guidant, we have spent more than a year planning an integration that will create an extraordinary cardiovascular device business that can deliver better medical treatment sooner to millions of patients. We strongly believe that our union with Guidant is the only one that can deliver on that promise and create lasting value for shareholders of both companies.
William Weldon
Most 'silent' heart attacks really aren't silent; they're just not noticed. If questioned carefully, many patients will recall some vague symptoms, such as indigestion or back pain, that they blamed on something else at the time.
Richard Stein
Nordsprog.dk
Antal ordsprog er 1469561
varav 1490770 på nordiska
Ordsprog
(1469561 st)
Søg
Kategorier
(2627 st)
Søg
Kilder
(167535 st)
Søg
Billeder
(4592 st)
Født
(10495 st)
Døde
(3318 st)
Datoer
(9517 st)
Lande
(5315 st)
Idiom
(4439 st)
Lengde
Topplistor
(6 st)
Ordspråksmusik
(20 st)
Statistik
søg
i ordsprogene
i kilderne
i kategorierne
overalt
Denna sidan visar ordspråk som liknar "Patients may also get discouraged given the [implantable heart defibrillator] recall activity that has occurred at Guidant and to a lesser extent at Medtronic and St. Jude of late.".